Clinical Trial Update: Relieving Burden of Hypophosphatasia in Adults With Functional Impairment Due to Chronic Disease [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial investigating relief of functional impairment in adults with hypophosphatasia has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypophosphatasia

Snippet

Sponsor: Alexion Pharmaceuticals, Inc. | Conditions: Hypophosphatasia | Phase 4 | Status: WITHDRAWN